Bajaj HealthCare Intrinsic Value
Bajaj HealthCare (BAJAJHCARE) median intrinsic value is ₹195.18 from 9 valuation models (range ₹99–₹661), vs current price ₹330.55 — -41.0% downside (Trading Above Calculated Value), margin of safety -69.4%. See BAJAJHCARE P/B ratio to compare market price against book value per share.
BAJAJHCARE Valuation Methods Summary — DCF, Graham Number & P/E
Bajaj HealthCare intrinsic value across 9 models vs current price ₹330.55 — upside/downside and value range per method. For current market price and key ratios, visit BAJAJHCARE share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹118.80 | ₹95.04 - ₹142.56 | -64.1% | EPS: ₹5.40, Sector P/E: 22x |
| Book Value Method | asset | ₹627.06 | ₹564.35 - ₹689.77 | +89.7% | Book Value/Share: ₹313.53, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹661.10 | ₹594.99 - ₹727.21 | +100.0% | Revenue/Share: ₹373.53, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹458.82 | ₹412.94 - ₹504.70 | +38.8% | EBITDA: ₹78.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹463.43 | ₹370.74 - ₹556.12 | +40.2% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹99.17 | ₹89.25 - ₹109.09 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹99.17 | ₹89.25 - ₹109.09 | -70.0% | Revenue Growth: -0.5%, Adj P/E: 15.0x |
| Graham Defensive Method | conservative | ₹195.18 | ₹175.66 - ₹214.70 | -41.0% | EPS: ₹5.40, BVPS: ₹313.53 |
| Dividend Yield Method | dividend | ₹99.17 | ₹89.25 - ₹109.09 | -70.0% | DPS: ₹1.50, Target Yield: 2.5% |
BAJAJHCARE Intrinsic Value vs Market Price — All Valuation Models
Bajaj HealthCare fair value range ₹99–₹661 vs current market price ₹330.55 across 9 valuation models. Check BAJAJHCARE market capitalization to track the company's total market size over time.
BAJAJHCARE Intrinsic Value Analysis — Undervalued or Overvalued?
Bajaj HealthCare median intrinsic value ₹195.18, current price ₹330.55 — Trading Above Calculated Value by 41.0%, margin of safety -69.4%.
What is the intrinsic value of BAJAJHCARE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Bajaj HealthCare (BAJAJHCARE) is ₹195.18 (median value). With the current market price of ₹330.55, this represents a -41.0% variance from our estimated fair value.
The valuation range spans from ₹99.17 to ₹661.10, indicating ₹99.17 - ₹661.10.
Is BAJAJHCARE undervalued or overvalued?
Based on our multi-method analysis, Bajaj HealthCare (BAJAJHCARE) appears to be trading above calculated value by approximately 41.0%.
BAJAJHCARE Financial Health — Key Ratios vs Industry Benchmarks
Bajaj HealthCare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.11 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.69x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BAJAJHCARE Cash Flow Quality — Operating & Free Cash Flow
Bajaj HealthCare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹58 Cr | ₹34 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹22 Cr | ₹15 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹92 Cr | ₹87 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-22 Cr | ₹-69 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹-37 Cr | Positive Operating Cash Flow | 6/10 |